UCLA Semel Institute — Los Angeles, California

UCLA Semel Institute is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

UCLA Semel Institute has participated in 35 clinical trials with 5 currently active.

Therapeutic areas: Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder, Adolescents.

Sponsors: Think Now Incorporated, University of California, Los Angeles, Health Resources and Services Administration (HRSA).

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Semel Institute?

UCLA Semel Institute has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Semel Institute conducted?

UCLA Semel Institute has 35 clinical trials on record, with 5 currently active. Their work covers Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder, Adolescents.

Is UCLA Semel Institute accredited by Crixeo Health?

Yes — UCLA Semel Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UCLA Semel Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.